Purchase Order VA24913P0640

This is a sole-source firm-fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Prevention Genetics LLC, a for-profit limited liability company, to provide specialized genetic testing services. The contract, valued at $60,000.00, is for the continuation of genetic analysis of the TNXB and CAH-X genes to support the NIH's ongoing Natural History Study of Patients with Excess Androgens, protocol #06-CH-0011. Prevention Genetics is the only CLIA-certified...

This is a firm fixed-price blanket purchase agreement (BPA) call award issued by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics. The $150,000.00 contract is for newborn screening tests and does not have a set-aside designation. Perkinelmer Genetics is a for-profit subsidiary of Revvity Inc. that specializes in medical imaging and genetic testing services, particularly newborn screening programs that test infants for conditions like...

This firm fixed-price delivery order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the provision of APTIMA COMBO 2 ASSAY (CT/GC) testing services for the Naval Medical Center San Diego. The contract has a ceiling value of $372,400.00 and a period of performance through July 7, 2023. Gen-Probe is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the...

Revvity Omics Inc., operating as Perkinelmer Genetics, received a $4,549.50 firm fixed-price delivery order from the Defense Health Agency for newborn screening testing services at Brian D. Allgood Army Community Hospital in South Korea. This delivery order, awarded on July 1, 2025, with completion scheduled for September 28, 2025, represents a task order issued under Revvity Omics Inc.'s larger Indefinite Delivery Contract valued at $301,668 and awarded to the same facility on September 29,...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Genedx, LLC, a subsidiary of Opko Health, Inc. The $25,000.00 firm fixed-price purchase order is for the provision of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. The contract has a completion date of June 30, 2025. Genedx is the prime...

The Department of the Army Medical Command awarded a $37,989.49 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services at Brian D. Allgood Army Community Hospital/121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide these services from September 2020 through September 2021 in support of the hospital's newborn screening program. Perkinelmer Genetics is a subsidiary of Revvity Inc., which focuses on medical...

The Department of the Army Medical Command awarded a $34,329.12 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services in support of the Brian D. Allgood Army Community Hospital and 121st Combat Support Hospital in Korea. The testing will be conducted under an Other Transaction for Prototype III agreement and is to be completed by September 28, 2023. Perkinelmer Genetics, Inc. is a subsidiary of Revvity Inc., which operates in the medical imaging...

This federal contract award, with an ID of 75N90018K00052, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The $82,281.25 firm fixed-price purchase order is for medical laboratory testing services, primarily to support research and clinical programs at the NIH. Genedx, a wholly-owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic services to the federal government. This...

This federal contract award, with ID HHSN269201700325PC, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The contract is for $95,385.00 and is for medical laboratory testing services, specifically supporting genetic testing and analysis. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market for this award. Genedx, as a wholly owned subsidiary of...